Agenda

Showcasing a curated group of high-potential companies developing the next generation of medical technologies and devices for female patients. Six selected finalists will present clinically validated, application-focused innovations in a rapid-fire format to an audience of pharmaceutical leaders, medical device companies, providers, investors, and strategic partners across the women's health ecosystem. The session is designed to highlight technologies that can integrate into care pathways, improve clinical outcomes, and scale within real-world healthcare settings, while providing a platform for companies to build visibility, credibility, and meaningful connections across the market. Finalists gain exposure to decision-makers across clinical, commercial, and innovation functions, while contributing to a broader view of how medical technologies are reshaping women's health delivery and treatment. Format: ' 6 finalist companies ' 7-minute presentation per company ' 2-minute moderated Q&A with expert judges ' Audience and Judges' Choice winners announced at the end of the day Finalists will be selected based on: ' strength and differentiation of the technology ' level of clinical validation and real-world applicability ' ability to integrate into care pathways and clinical workflows potential to scale, adopt, and deliver measurable outcomes

Judges:

Elizabeth Bailey, Co-Founder & Managing Partner, Foreground Capital

Mané Mikayelyan, Associate Partner, DeciBio Consulting

Karla Loken, Founder, Loken & Associates